Dr. Mautner will study 500 patients over two years. Dr. Mautner believes his study is one of the largest-ever stem cell studies.
“We’re trying to do the right thing. We are trying to move the field forward as well as help patients feel better,” he told Fox 5.
More articles on biologics:
FDA warns Orchid Orthopedics about Michigan facility compliance: 3 details
Reprocessed pedicle screws carry high levels of contamination — 5 insights
42 device company executive moves in 2019
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
